'GILDing' The Lilly: Vaccines, Treatments For Virus In Spotlight Ahead Of Health Care Q2 Earnings

After a few years hanging out quietly on the sidelines, the Health Care sector roared back to prominence this year as Covid-19 ravaged the globe. Suddenly, vaccines and antibodies catapulted into the headlines, drawing attention to biotech and pharma amid a race to treat or prevent the virus.